Simplex Trading’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-176,900
| Closed | -$4.18M | – | 10244 |
|
|
2023
Q4 | $4.18M | Buy |
176,900
+116,300
| +192% | +$2.07M | ﹤0.01% | 1718 |
|
|
2023
Q3 | $903K | Sell |
60,600
-39,100
| -39% | -$518K | ﹤0.01% | 2767 |
|
|
2023
Q2 | $1.09M | Sell |
99,700
-18,600
| -16% | -$173K | ﹤0.01% | 2526 |
|
|
2023
Q1 | $1.03M | Buy |
118,300
+76,500
| +183% | +$612K | ﹤0.01% | 2565 |
|
|
2022
Q4 | $262K | Buy |
41,800
+25,400
| +155% | +$96.5K | ﹤0.01% | 3896 |
|
|
2022
Q3 | $57K | Sell |
16,400
-4,900
| -23% | -$17.6K | ﹤0.01% | 6267 |
|
|
2022
Q2 | $62K | Buy |
21,300
+13,300
| +166% | +$31.8K | ﹤0.01% | 6214 |
|
|
2022
Q1 | $24K | Sell |
8,000
-15,100
| -65% | -$47.5K | ﹤0.01% | 8063 |
|
|
2021
Q4 | $78K | Sell |
23,100
-6,500
| -22% | -$24.7K | ﹤0.01% | 6635 |
|
|
2021
Q3 | $130K | Hold |
29,600
| – | – | ﹤0.01% | 6251 |
|
|
2021
Q2 | $129K | Buy |
29,600
+29,327
| +10,742% | +$130K | ﹤0.01% | 6368 |
|
|
2021
Q1 | $123K | Buy |
+273
| New | +$1.47K | ﹤0.01% | 5447 |
|
|
2020
Q2 | – | Sell |
-57
| Closed | -$8K | – | 8569 |
|
|
2020
Q1 | $8K | Sell |
57
-35
| -38% | -$59 | ﹤0.01% | 6631 |
|
|
2019
Q4 | $18K | Buy |
92
+29
| +46% | +$109 | ﹤0.01% | 6041 |
|
|
2019
Q3 | $32K | Sell |
63
-293
| -82% | -$1.77K | ﹤0.01% | 5449 |
|
|
2019
Q2 | $254K | Buy |
356
+318
| +837% | +$3.6K | ﹤0.01% | 3234 |
|
|
2019
Q1 | $50K | Buy |
38
+10
| +36% | +$106 | ﹤0.01% | 5011 |
|
|
2018
Q4 | $22K | Sell |
28
-6
| -18% | -$57 | ﹤0.01% | 5261 |
|
|
2018
Q3 | $37K | Buy |
34
+14
| +70% | +$174 | ﹤0.01% | 5454 |
|
|
2018
Q2 | $26K | Sell |
20
-3
| -13% | -$38 | ﹤0.01% | 5667 |
|
|
2018
Q1 | $7K | Sell |
23
-18
| -44% | -$224 | ﹤0.01% | 4390 |
|
|
2017
Q4 | $15K | Buy |
41
+4
| +11% | +$34 | ﹤0.01% | 3591 |
|
|
2017
Q3 | $10K | Buy |
37
+34
| +1,133% | +$230 | ﹤0.01% | 3799 |
|
|
2017
Q2 | $1K | Buy |
+3
| New | +$13 | ﹤0.01% | 5801 |
|
Other funds holding CBAY
Simplex Trading's CBAY Position: Q4 2023 in Review
Simplex Trading sold out of Cymabay Therapeutics (CBAY) in Q4 2023, closing a stake of 55,629 shares — an estimated $991K sold.
Simplex Trading first reported a position in CBAY in Q3 2018 and held it in 14 quarters. The position peaked at $829K in Q3 2023. 200 funds tracked by Wall St. Rank hold CBAY as of Q4 2023.
- Simplex Trading reported no remaining Cymabay Therapeutics position as of Q4 2023 after selling out during the quarter.
- Simplex Trading sold 55,629 Cymabay Therapeutics shares in Q4 2023, an estimated $991K.
- Simplex Trading first reported a position in Cymabay Therapeutics in Q3 2018 and held it in 14 quarters.
- Simplex Trading's Cymabay Therapeutics position peaked at $829K in Q3 2023.
- 200 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q4 2023.
Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.